Dynamic thermography of the knee joints in rheumatoid arthritis (RA) in the course of the first therapy of the patient with methylprednisolone

2000 ◽  
Vol 59 (S2) ◽  
pp. 131-135 ◽  
Author(s):  
D. Rusch ◽  
M. Follmann ◽  
B. Boss ◽  
G. Neeck
Keyword(s):  
Rheumatoid Arthritis ◽  
Knee Joints ◽  
Dynamic Thermography

Evaluation of the Impact of the Whole-body Cryotherapy Treatment on the Functional Condition of the Knee Joints in Patients with Rheumatoid Arthritis

2021 ◽  
Vol 63 (2) ◽  
pp. 93-98
Author(s):  
Agnieszka Przedborska ◽  
Mateusz Szymczak ◽  
Małgorzata Kilon ◽  
Łukasz Kikowski ◽  
Jan Raczkowski
Keyword(s):  
Rheumatoid Arthritis ◽  
Muscle Strength ◽  
Range Of Motion ◽  
Functional State ◽  
Functional Condition ◽  
Knee Joints ◽  
Whole Body ◽  
Gait Function ◽  
Whole Body Cryotherapy ◽  
The Impact

Introduction: Rheumatoid arthritis (RA) is a chronic disease that leads to disability of patients. The use of the whole-body cryotherapy treatment for RA patients provides analgesic and anti-inflammatory effects and improves their efficiency. Aim: Assessment of the effect of the whole-body cryotherapy treatment on the functional state of knee joints for patients with RA. Material and Method: The study was conducted on a group of 30 RA patients, who underwent a series of 10 whole-body cryotherapy treatment. The effectiveness and efficiency of the applied therapy was assessed on the basis of: the VAS scale, the Laitinen scale, the assessment of the range of motion, muscle strength with the MicroFet dynamometer and the Up and Go test. Results: As a result of the applied whole-body cryotherapy treatment, a reduction in the intensity of pain, measured with the VAS scale and the Laitinen scale, and a reduction in the duration of morning stiffness by about 55% were found. There was an increase in the range of motion and muscle strength. The time needed to perform the Up and Go test was reduced by 17%. Conclusions: The whole-body cryotherapy treatment is an effective analgesic method of physiotherapy for patients with RA. It provides an improvement in the functional state, increases the range of motion, muscle strength and improves the gait function.

Isotope Studies in Normal and Diseased Knee Joints: 99mTc Uptake Related to Clinical Assessment and to Synovial Perfusion Measured by the 133Xe Clearance Technique

1971 ◽  
Vol 40 (4) ◽  
pp. 327-336 ◽  
Author(s):  
W. C. Dick ◽  
S. D. Deodhar ◽  
Carol J. Provan ◽  
G. Nuki ◽  
W. W. Buchanan
Keyword(s):  
Rheumatoid Arthritis ◽  
Normal Subjects ◽  
Knee Joints ◽  
133Xe Clearance ◽  
Normal Limits ◽  
Human Volunteers ◽  
Normal Human ◽  
Clinical Indices ◽  
Isotope Studies ◽  
The Mean

1. Uptake of intravenously administered radioactive technetium (99mTc) was measured over the knee joints in normal human volunteers, in patients with osteoarthritis and in groups of synovectomized and unoperated patients with rheumatoid arthritis. The uptake was compared with clinical indices of inflammation (pain, tenderness swelling and stiffness), and the clearance rate of intra-articularly injected radioactive xenon (133Xe). The 99mTc uptakes were found to be unrelated to the isotope dose and the day-to-day reproducibility was acceptable. 2. The mean uptake of 99mTc was within normal limits in osteoarthritis. Both in synovectomized and in unoperated rheumatoid arthritis 99mTc uptake was significantly higher than in normal subjects. 3. Of the clinical indices studied significant correlation of 99mTc uptake was found with pain and swelling in all groups of patients studied. 4. Faster clearance of 133Xe in unoperated rheumatoid arthritis correlated well with the higher 99mTc uptakes. 5. The results confirm that 99mTc uptakes are raised in inflammatory arthritis but not in degenerative arthritis. The relation of 99mTc uptake to the clinical indices of inflammation and to the 133Xe clearance from the joint is discussed.

IMMUNOHISTOLOGICAL FEATURES IN THE SYNOVIUM OBTAINED FROM CLINICALLY UNINVOLVED KNEE JOINTS OF PATIENTS WITH RHEUMATOID ARTHRITIS

Rheumatology ◽  
1989 ◽  
Vol 28 (4) ◽  
pp. 287-292 ◽  
Author(s):  
MURIEL SODEN ◽  
MADELEINE ROONEY ◽  
A. CULLEN ◽  
A. WHELAN ◽  
C. FEIGHERY ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Knee Joints

scholarly journals CLINICAL EVALUATION OF VAITARANA BASTI ALONG WITH DHANWANTARA TAILA MATRA BASTI IN AMAVATA: A CASE SERIES

2020 ◽  
Vol 11 (6) ◽  
pp. 12-15
Author(s):  
Sheetal G Lodha ◽  
Ruchika S Karade
Keyword(s):  
Rheumatoid Arthritis ◽  
Connective Tissue ◽  
Rheumatoid Factor ◽  
Morning Stiffness ◽  
Dominant Role ◽  
Case Series ◽  
Signs And Symptoms ◽  
The Other ◽  
Knee Joints ◽  
The Common

Amavata is one of the common and most crippling joint disorders. It is a chronic, degenerative disease of the connective tissue mainly involving the joints. The clinical features of Amavata such as pain, swelling and stiffness of joints, fever and general disability are very much close to the Rheumatological disorder called rheumatoid arthritis. Ama associated with aggravated vata plays a dominant role in the pathogenesis of Amavata. According to its pathophysiology, one should treat the morbid doshas involve in are kapha and vata simultaneously. In the present study, four clinically diagnosed cases of Amavata with swelling of knee joints and morning stiffness , pain in multiple joints, raised rheumatoid factor and anti CCP factor are treated with Vaitarana basti along with Dhanwantara taila Matra basti on same day and changes are observed in subjective and objective criteria. Significant improvement is observed in reducing signs and symptoms of Amavata and in rheumatoid arthritis factor and anti CCP. Vaitarana basti eradicate Ama and kapha dosha as the drugs of Vaitarana basti having Ama pachaka, vatakapha shamaka and Anulomaka properties. On the other hand, Matra basti of Dhanwantara taila pacifies the vatadosha and reduced the pain and swelling. It also acts as neuroprotective, analgesic, anti-inflammatory, anti-arthritic and anti-paralytic. The combination of Vaitarana basti and Dhanwantara taila Matra basti can be an effective treatment for Amavata.

scholarly journals Susceptibility of Cyclin-dependent Kinase Inhibitor-1–deficient Mice to Rheumatoid Arthritis From IL-1β–induced Inflammation

2020 ◽  
Author(s):  
Yoshinori Takashima ◽  
Shinya Hayashi ◽  
Koji Fukuda ◽  
Toshihisa Maeda ◽  
Masanori Tsubosaka ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Monoclonal Antibodies ◽  
Kinase Inhibitor ◽  
Joint Inflammation ◽  
Type Ii Collagen ◽  
Cartilage Destruction ◽  
Knee Joints ◽  
Inflammatory Disorder ◽  
Cyclin Dependent Kinase ◽  
And Cartilage

Abstract Background: Rheumatoid arthritis (RA) is a chronic and systemic inflammatory disorder whose progression is modulated by fibroblast-like synoviocytes (FLSs). Cyclin-dependent kinase (CDK) inhibitor 1 (p21) regulates the activation of other CDKs, and we recently reported that p21 deficiency induces susceptibility to osteoarthritis. Here, we focused on joint inflammation to determine the mechanisms associated with p21 function in synovial and cartilage tissues in RA.Methods: p21-knockout (p21-/-) mice and wild-type C57BL/6 (WT p21+/+) mice were used to establish a collagen antibody-induced arthritis (CAIA) model. The severity of arthritis was evaluated visually, and histological and immunohistological analyses performed 7, 14, and 28 days after injection with a cocktail of five monoclonal antibodies that recognize conserved epitopes on various species of type II collagen. The response of p21 siRNA-treated human RA FLSs to IL-1β stimulation was also determined.Results: Arthritis scores were higher in p21-/- mice than those in p21+/+ mice. More severe and prolonged synovitis of the knee joints and earlier loss of staining and cartilage destruction were observed in p21-/- mice than in p21+/+ mice. p21-/- mice expressed higher levels of IL-1β, F4/80, p-IKKα/β, and MMPs in cartilage and synovial tissues at each time point, except for before injection of the monoclonal antibodies, via IL-1β-induced NF-kB signaling. IL-1β stimulation significantly increased MMP expression and enhanced IKKα/β phosphorylation in human FLSs.Conclusion: p21-deficient CAIA mice are susceptible to alterations in the RA phenotype, including joint cartilage destruction and severe synovitis, via IL-1β-induced inflammation. Therefore, p21 regulation may constitute a possible strategy for RA treatment.

Sign in / Sign up

Export Citation Format

Share Document